Invention Grant
- Patent Title: PI3K/AKT/mTOR inhibitors and pharmaceutical uses thereof
-
Application No.: US15025086Application Date: 2014-09-24
-
Publication No.: US09656984B2Publication Date: 2017-05-23
- Inventor: Mickael Jean , Amélie Fouque , Patrick Legembre , Pierre Van De Weghe
- Applicant: UNIVERSITE DE RENNES 1 , Centre national de la recherche scientifique , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Applicant Address: FR Rennes FR Paris FR Paris
- Assignee: UNIVERSITE DE RENNES 1,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee: UNIVERSITE DE RENNES 1,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee Address: FR Rennes FR Paris FR Paris
- Agency: Troutman Sanders LLP
- Priority: EP13306312 20130925
- International Application: PCT/EP2014/070409 WO 20140924
- International Announcement: WO2015/044229 WO 20150402
- Main IPC: C07D311/60
- IPC: C07D311/60 ; C07D335/06 ; C07D407/04 ; C07D495/04 ; C07D493/10 ; C07D409/04 ; C07D311/64
Abstract:
The invention relates to new PI3K/AKT/m TOR inhibitors and their use for the prevention and/or the treatment of a disease selected from the group consisting of: inflammatory diseases, autoimmune diseases, neurodegenerative diseases, cancers, transplant rejection, diseases characterized by a premature aging and tuberous sclerosis.
Public/Granted literature
- US20160244424A1 NEW PI3K/AKT/MTOR INHIBITORS AND PHARMACEUTICAL USES THEREOF Public/Granted day:2016-08-25
Information query
